Home > Formulary : Paediatric > Paediatric Chapters > 6. Endocrine system >
BNSSG Paediatric Joint Formulary
6.9 Obesity
Last edited: 07-10-2025
6.9 Obesity
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
Orlistat (TLS Red)
Semaglutide (Wegovy) for severe obesity in children (TLS Red)
- Approved for children and young people between 12 and 18 years of age with severe obesity as an option for weight management as an adjuvant to lifestyle modification
- Use is via Prior Approval Scheme as per the criteria on Blueteq